PRN: Global IVD Market Research Package 2017: 4 Reports Evaluating the $61 Billion Dollar Industry - Research and Markets

18/apr/2017 15:02:51 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global IVD Market Research Package 2017: 4 Reports Evaluating the $61 Billion Dollar Industry - Research and Markets


DUBLIN, April 18, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "2017 IVD Market Research Bundle (The Worldwide Market for In Vitro Diagnostic Tests, NGS, Companion, US IVD)" report to their offering.

Research and Markets Logo

The IVD market is estimated to be nearly 61 billion dollars.

There are a number of drivers of the market that should be watched in 2017.  The IVD industry has been the beneficiary of genomic research and unfortunately the march of obesity, diabetes, cancer, cardiac disease and infectious diseases, worldwide.These situations have created demand for highly specific, sensitive and sometimes expensive tests.    

This bundle of previously published studies allows decision-makers and researchers to review critical information in order to be prepared for events coming in 2017.  

These topics fit together well as the IVD industry integrates next-generation sequencing into clinical diagnostics, reaches for companion opportunities and specifically targets the world's largest healthcare market. The bundle contains the full reports as they were published.

Studies Included:

  • The World Market for In Vitro Diagnostics, 10th Edition - Published August 2016
  • United States In Vitro Diagnostics Markets - Published July 2016
  • Companion Diagnostic Testing Markets - Published April 2016
  • Next Generation Sequencing Markets - Published September 2016

Companies Mentioned

    • AB SCIEX Pte Ltd
    • Abbott Diagnostics
    • Affymetrix Inc
    • Agilent Technologies
    • Alere Inc
    • Animas Corporation
    • Angle plc
    • ApoCell, Inc
    • Arkray
    • Ascensia Diabetes Care (formerly Bayer Diabetes Care)
    • Beckman Coulter, Inc.
    • Becton, Dickinson and Company (BD)
    • Bigfoot Biomedical
    • Biocept, Inc
    • Biodesix, Inc
    • bioMérieux Inc
    • Bio-Rad Laboratories, Inc
    • Bruker BioSciences Corporation
    • CellaVision AB
    • Debiotech SA
    • DexCom, Inc
    • Diagnostica Stago, S.A.S
    • Eiken Chemical Co., Ltd
    • EliTech Group S.A.S
    • Epic Sciences Inc
    • ERBA Mannheim
    • Fujirebio Diagnostics, Inc
    • Gentag, Inc
    • Glytec Inc
    • Haemokinesis Pty Ltd
    • Hologic, Inc
    • iHealth Lab Inc
    • Immucor, Inc
    • LabCorp, Laboratory Corporation of America
    • Lifescan Inc
    • Luminex Corporation
    • Mindray Medical International Limited
    • Myriad Genetics
    • Oncascan Limited
    • PerkinElmer, Inc. (PE)
    • QIAGEN N.V
    • Quest Diagnostics
    • Roche Diagnostics
    • Savanna (formerly Wildcat)
    • Siemens Healthcare Diagnostics
    • Solana Molecular System
    • Tandem Diabetes Care, Inc
    • Verily (formerly Google Life Sciences)
    • West Medica

    For more information about this report visit

    Media Contact:

    Research and Markets
    Laura Wood, Senior Manager

    For E.S.T Office Hours Call +1-917-300-0470
    For U.S./CAN Toll Free Call +1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900

    U.S. Fax: 646-607-1907
    Fax (outside U.S.): +353-1-481-1716


    blog comments powered by Disqus è un servizio offerto da Factotum Srl